Posted by Michael Wonder on 05 Aug 2015
[:content [\2 \1 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \ \I \n \space \n \e \w \ \d \r \a \f \t \space \g \u \i \d \a \n \c \e \ \p \u \b \l \i \s \h \e \d \space \t \o \d \a \y \space \( \2 \1 \space \M \a \r \c \h \) \, \space \N \I \C \E \space \h \a \s \space \r \e \c \o \m \m \e \n \d \e \d \space \b \o \r \t \e \z \o \m \i \b \space \( \V \e \l \c \a \d \e \) \space \a \s \space \a \space \t \r \e \a \t \m \e \n \t \space \f \o \r \space \s \o \m \e \space \p \a \t \i \e \n \t \s " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\T \h \e \space \c \a \l \l \space \f \o \r \space \p \u \b \l \i \c \space \s \u \b \m \i \s \s \i \o \n \s \space \i \s \space \n \o \w \space \o \p \e \n \space \f \o \r \space \S \t \a \g \e \space \3 \space \o \f \space \t \h \e \space \D \i \a \b \e \t \e \s \space \R \e \v \i \e \w \space \f \o \r \space \a \space \p \e \r \i \o \d \space \o \f \space \s \i \x " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\B \r \i \s \t \o \l \- \M \y \e \r \s \space \S \q \u \i \b \b \space \C \a \n \a \d \a \space \h \a \s \space \a \n \n \o \u \n \c \e \d \space \t \h \a \t \space \t \h \e \space \C \o \m \m \o \n \space \D \r \u \g \space \R \e \v \i \e \w \space \h \a \s \space \r \e \c \o \m \m \e \n \d \e \d \space \t \h \a \t \space \t \h \e \space \s \e \l \f \- \i \n \j \e \c \t \a \b \l \e \space \s \u \b \c \u \t \a \n \e \o \u \s \space \f \o \r \m \u \l \a \t \i \o \n \space \o \f \space \t \h \e \space \r \h \e \u \m \a \t \o \i \d " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\1 \1 \space \J \a \n \u \a \r \y \space \2 \0 \1 \4 \space \- \ \A \c \c \u \s \a \t \i \o \n \s \space \t \h \a \t \space \o \f \f \i \c \i \a \l \s \space \a \t \space \N \I \C \E \space \h \a \v \e \space \u \s \e \d \space \c \r \e \d \i \t \space \c \a \r \d \s \space \o \n \space \l \u \x \u \r \y \space \h \o \t \e \l \s \space \a \n \d \space \c \h \a \m \p \a \g \n \e \space \b \a \r \s \space \a \r \e \space \r \e \p \o \r \t \e \d " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
CADTH is pleased to announce that it is now accepting requests to register for the 2015 CADTH Symposium being held at the TCU Place, ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Pancreatic cancer drug Abraxane will be listed on the PBS from November 1.
The Australian Government has committed over $92 million ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\1 \2 \space \N \o \v \e \m \b \e \r \space \2 \0 \1 \3 \space \- \ \B \a \y \e \r \space \I \n \c \. \space \a \n \n \o \u \n \c \e \d \space \t \h \a \t \space \i \t \space \h \a \s \space \r \e \c \e \i \v \e \d \space \a \p \p \r \o \v \a \l \space \f \r \o \m \space \H \e \a \l \t \h \space \C \a \n \a \d \a \space \f \o \r \space \E \y \l \e \a \space \( \a \f \l \i \b \e \r \c \e \p \t \, \space \s \o \l \u \t \i \o \n \space \f \o \r \space \i \n \t \r \a \v \i \t \r \e \a \l " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
The 1 November 2014 issue of the Schedule of Pharmaceutical Benefits is now available and in effect. The new issue contains ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\2 \6 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \ \S \o \m \e \space \p \a \t \i \e \n \t \s \space \w \i \t \h \space \a \n \space \a \g \g \r \e \s \s \i \v \e \space \t \y \p \e \space \o \f \space \n \o \n \- \H \o \d \g \k \i \n \' \s \space \l \y \m \p \h \o \m \a \space \- \space \a \space \c \a \n \c \e \r \space \t \h \a \t \space \d \e \v \e \l \o \p \s \space \i \n \space \t \h \e \space \b \o \d \y \' \s " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
NICE has updated its website; the URLs for all Appraisal Consultation Documents and Final Appraisal Determinations have changed. The links in ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Sir Hugh Taylor writes on the work of the Accelerated Access Review to improve access to innovative healthcare for NHS ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Takeda’s Entyvio (vedolizumab) has become the first biologic therapy to get a provisional yes from the National Institute for Health ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
The PBAC minutes from the July 2014 meeting on the post-market review of PBS medicines used to treat asthma in ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
PHARMAC is seeking feedback on a proposal to fund preservative free prednisolone sodium phosphate 0.5% eye drops, resulting from a ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
UK babies will be the first worldwide to be routinely vaccinated against meningitis B, after the UK government finally reached ...
Read more →